dapsone has been researched along with Acute Disease in 33 studies
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While methemoglobinemia is a possible complication of chronic dapsone therapy or of acute overdose, serious adverse manifestations related to methemoglobin formation remain rare." | 7.81 | Acute visual loss following dapsone-induced methemoglobinemia and hemolysis. ( Hantson, P; Hanuschk, D; Kozyreff, A; Saint-Marcoux, F; Tafzi, N; Tennstedt, D, 2015) |
| "The relative risks of non-specific upper respiratory tract infections were studied in two well matched groups of military recruits to see whether dapsone-pyrimethamine (Maloprim) given as antimalarial prophylaxis was associated with immunosuppression." | 7.67 | Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria. ( Lau, EY; Lee, PS, 1988) |
| "While methemoglobinemia is a possible complication of chronic dapsone therapy or of acute overdose, serious adverse manifestations related to methemoglobin formation remain rare." | 3.81 | Acute visual loss following dapsone-induced methemoglobinemia and hemolysis. ( Hantson, P; Hanuschk, D; Kozyreff, A; Saint-Marcoux, F; Tafzi, N; Tennstedt, D, 2015) |
| "Two soldiers continued weekly prophylaxis with 300 mg chloroquine base on their return to Australia from Papua New Guinea but were not protected against Plasmodium vivax malaria." | 3.67 | Plasmodium vivax resistance to chloroquine? ( Davis, DR; Hutton, DC; Rieckmann, KH, 1989) |
| "The relative risks of non-specific upper respiratory tract infections were studied in two well matched groups of military recruits to see whether dapsone-pyrimethamine (Maloprim) given as antimalarial prophylaxis was associated with immunosuppression." | 3.67 | Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria. ( Lau, EY; Lee, PS, 1988) |
| " Further studies are required to establish its role and the optimal dosage regimen of charcoal to be administered." | 2.40 | Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. ( , 1999) |
| " Drug-induced acute hemolytic anemia in G6PD A- subjects can be life-threatening, depending on the nature and dosage of the drug trigger." | 1.38 | Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. ( Carter, N; Duparc, S; Luzzatto, L; Pamba, A; Premji, Z; Richardson, ND; Tiono, AB, 2012) |
| "Epidermolysis bullosa acquisita is a rare entity belonging to the auto-immune cutaneous blistering disorders of the dermo-epidermal junction." | 1.36 | [Acute pseudo-membranous laryngitis in epidermolysis bullosa acquisita]. ( Besancenot, JF; Folia, M; Gilbert, D; Lecomte, H; Muller, G; Romanet, P; Tron, F, 2010) |
| "We describe a patient with systemic lupus erythematosus (SLE) who exhibited severe cutaneous involvement characterized by the simultaneous presence of acute, subacute and discoid lesions in association with anti-S1 antibodies." | 1.30 | A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. ( Bernacchi, E; Bombardieri, S; Mosca, M; Neri, R, 1999) |
| "Six cases of pneumocystis carinii pneumonia were retrospectively analyzed." | 1.30 | [A clinical study of six cases of Pneumocystis carinii pneumonia]. ( Lin, X; Wu, S, 1998) |
| "Thus epiroprim is an active and potentially less toxic alternative pyrimethamine for the treatment of toxoplasmosis." | 1.29 | Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice. ( Allegra, CJ; Kovacs, JA; Martinez, A, 1996) |
| " Plasma dapsone concentrations declined mono-exponentially with time, and the half-life (29." | 1.27 | Acute dapsone poisoning: clinical features and pharmacokinetic studies. ( Charlton, B; Henderson, DB; Peaston, RT; Rawlins, MD; Woodhouse, KW, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (42.42) | 18.7374 |
| 1990's | 7 (21.21) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 6 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drerup, C | 1 |
| Hake, L | 1 |
| Oji, V | 1 |
| Sunderkötter, C | 1 |
| Navarro-Mingorance, A | 1 |
| Castellanos-Alcarria, AJ | 1 |
| Ibañez-Micó, S | 1 |
| Cervantes-Pardo, A | 1 |
| Sánchez-Pedreño, P | 1 |
| Hanuschk, D | 1 |
| Kozyreff, A | 1 |
| Tafzi, N | 1 |
| Tennstedt, D | 1 |
| Hantson, P | 1 |
| Saint-Marcoux, F | 1 |
| Narasimharao, P | 1 |
| Pratap, DV | 1 |
| Suneetha, S | 1 |
| Sheetal, S | 1 |
| Arvind, C | 1 |
| Lecomte, H | 1 |
| Folia, M | 1 |
| Muller, G | 1 |
| Gilbert, D | 1 |
| Tron, F | 1 |
| Besancenot, JF | 1 |
| Romanet, P | 1 |
| Narayanan, N | 1 |
| Conlon, N | 1 |
| Seigne, P | 1 |
| Pamba, A | 1 |
| Richardson, ND | 1 |
| Carter, N | 1 |
| Duparc, S | 1 |
| Premji, Z | 1 |
| Tiono, AB | 1 |
| Luzzatto, L | 1 |
| Al-Raqum, HA | 1 |
| Uppal, SS | 1 |
| El Abdalghani, RA | 1 |
| Lasheen, I | 1 |
| Wenzel, J | 1 |
| Bieber, T | 1 |
| Uerlich, M | 1 |
| Tüting, T | 1 |
| Shadnia, S | 1 |
| Rahimi, M | 1 |
| Moeinsadat, M | 1 |
| Vesal, G | 1 |
| Donyavi, M | 1 |
| Abdollahi, M | 1 |
| McCormack, LS | 1 |
| Elgart, ML | 1 |
| Turner, ML | 1 |
| Aram, H | 1 |
| Woodhouse, KW | 1 |
| Henderson, DB | 1 |
| Charlton, B | 1 |
| Peaston, RT | 1 |
| Rawlins, MD | 1 |
| Menendez, C | 1 |
| Todd, J | 1 |
| Alonso, PL | 1 |
| Lulat, S | 1 |
| Francis, N | 1 |
| Greenwood, BM | 1 |
| Chawla, R | 1 |
| Gurnani, A | 1 |
| Bhattacharya, A | 1 |
| Martinez, A | 1 |
| Allegra, CJ | 1 |
| Kovacs, JA | 1 |
| Neri, R | 1 |
| Mosca, M | 1 |
| Bernacchi, E | 1 |
| Bombardieri, S | 1 |
| Wu, S | 1 |
| Lin, X | 1 |
| Falkenhahn, M | 1 |
| Kannan, S | 1 |
| O'Kane, M | 1 |
| Sehgal, VN | 1 |
| Rege, VL | 1 |
| Mascarenhas, MF | 1 |
| Sahoo, SK | 1 |
| Tripathy, N | 1 |
| Debi, BP | 1 |
| Browne, SG | 2 |
| Hironaga, M | 1 |
| Mochizuki, T | 1 |
| Watanabe, S | 1 |
| Rustin, MH | 1 |
| Bunker, CB | 1 |
| Levene, GM | 1 |
| Meylan, PR | 1 |
| Markert, M | 1 |
| Bille, J | 1 |
| Glauser, MP | 1 |
| Rieckmann, KH | 1 |
| Davis, DR | 1 |
| Hutton, DC | 1 |
| Lee, PS | 1 |
| Lau, EY | 1 |
| Laing, AB | 2 |
| Gooi, HC | 1 |
| Gelber, RH | 1 |
| Wolfensberger, HR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-centre, Randomised, Double-blind, Double Dummy Study Comparing the Efficacy and Safety of Chlorproguanil-dapsone-artesunate Versus Artemether-lumefantrine in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children and Adoles[NCT00344006] | Phase 3 | 1,395 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| A Multi-centre, Randomised, Double-blind Study to Compare the Efficacy and Safety of Chlorproguanil-dapsone-artesunate Versus Chlorproguanil-dapsone in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children, Adolescents and Adults [NCT00371735] | Phase 3 | 900 participants (Actual) | Interventional | 2006-04-30 | Completed | ||
| Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine (PQ) for the Treatment of Uncomplicated Plasmodium Vivax Infection[NCT02691910] | Phase 2/Phase 3 | 204 participants (Actual) | Interventional | 2014-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dapsone and Acute Disease
| Article | Year |
|---|---|
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimal | 2003 |
Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
Topics: Acute Disease; Animals; Carbamazepine; Cathartics; Charcoal; Dapsone; Drug Therapy, Combination; Hum | 1999 |
2 trials available for dapsone and Acute Disease
| Article | Year |
|---|---|
Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae.
Topics: Acute Disease; Antimalarials; Birth Weight; Chronic Disease; Dapsone; Double-Blind Method; Drug Comb | 1994 |
Studies on the chemotherapy of malaria. I. The treatment of overt falciparum malaria with potentiating combinations of pyrimethamine and sulphormethoxine or dapsone in The Gambia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Dapsone; Drug Resistan | 1970 |
29 other studies available for dapsone and Acute Disease
| Article | Year |
|---|---|
Recurrent acute hemorrhagic edema of infancy (AHEI) during puberty.
Topics: Acute Disease; Adolescent; Age of Onset; Dapsone; Ecchymosis; Edema; Female; Hemorrhage; Humans; Pub | 2018 |
Dapsone-induced isolated acute pancreatitis in a child with linear IgA dermatitis.
Topics: Acute Disease; Child, Preschool; Dapsone; Dermatitis; Humans; Immunoglobulin A; Male; Pancreatitis | 2014 |
Acute visual loss following dapsone-induced methemoglobinemia and hemolysis.
Topics: Acute Disease; Adult; Dapsone; Drug Overdose; Female; Hemolysis; Humans; Ischemia; Methemoglobinemia | 2015 |
Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
Topics: Acute Disease; Adult; Dapsone; Drug Eruptions; Humans; Leprostatic Agents; Leprosy; Male; Skin Disea | 2009 |
Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
Topics: Acute Disease; Aged; Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combina | 2009 |
[Acute pseudo-membranous laryngitis in epidermolysis bullosa acquisita].
Topics: Acute Disease; Aged, 80 and over; Anti-Infective Agents; Dapsone; Deglutition Disorders; Drug Therap | 2010 |
Acute methaemoglobinaemia secondary to intentional dapsone overdose.
Topics: Acute Disease; Adult; Anti-Infective Agents; Dapsone; Female; Humans; Methemoglobinemia; Methylene B | 2010 |
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Topics: Acute Disease; Adolescent; Africa; Anemia, Hemolytic; Antimalarials; Blood Transfusion; Child; Child | 2012 |
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Topics: Acute Disease; Adolescent; Africa; Anemia, Hemolytic; Antimalarials; Blood Transfusion; Child; Child | 2012 |
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Topics: Acute Disease; Adolescent; Africa; Anemia, Hemolytic; Antimalarials; Blood Transfusion; Child; Child | 2012 |
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Topics: Acute Disease; Adolescent; Africa; Anemia, Hemolytic; Antimalarials; Blood Transfusion; Child; Child | 2012 |
First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
Topics: Acute Disease; Adult; Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combin | 2006 |
Acute methemoglobinemia following attempted suicide by Dapson.
Topics: Acute Disease; Adolescent; Arteries; Blood Cell Count; Blood Gas Analysis; Dapsone; Female; Hospital | 2006 |
Annular subacute cutaneous lupus erythematosus responsive to dapsone.
Topics: Acute Disease; Aged; Child, Preschool; Dapsone; Facial Dermatoses; Female; Follow-Up Studies; Humans | 1984 |
Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone.
Topics: Acute Disease; Adult; Dapsone; Female; Fever; Humans; Leukocyte Count; Neutrophils; Skin; Skin Disea | 1984 |
Acute dapsone poisoning: clinical features and pharmacokinetic studies.
Topics: Acute Disease; Dapsone; Humans; Kinetics; Male; Middle Aged | 1983 |
Acute dapsone poisoning.
Topics: Acute Disease; Adult; Dapsone; Humans; Leprosy; Male; Methemoglobinemia; Suicide, Attempted; Sulfhem | 1993 |
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Dapsone; | 1996 |
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Hum | 1999 |
[A clinical study of six cases of Pneumocystis carinii pneumonia].
Topics: Acute Disease; Adult; Aged; Anemia, Hemolytic, Autoimmune; Anti-Infective Agents; Dapsone; Female; H | 1998 |
Unexplained acute severe methaemoglobinaemia in a young adult.
Topics: Acute Disease; Adult; Dapsone; Female; Humans; Leprostatic Agents; Methemoglobinemia | 2001 |
Pattern of reactions in leprosy: a clinical appraisal.
Topics: Acute Disease; Adolescent; Adult; Child; Dapsone; Edema; Erythema Nodosum; Female; Humans; Leprosy; | 1977 |
Acute fatal DDS poisoning. (Report of 4 cases).
Topics: Acute Disease; Adolescent; Adult; Dapsone; Female; Humans; Male; Middle Aged; Suicide | 1979 |
The drug treatment of leprosy.
Topics: Acute Disease; Adrenal Cortex Hormones; Aniline Compounds; Clofazimine; Dapsone; Drug Therapy, Combi | 1975 |
Acute primary cutaneous nocardiosis.
Topics: Acute Disease; Child; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; M | 1990 |
Follicular mucinosis presenting as acute dermatitis and response to dapsone.
Topics: Acute Disease; Adult; Alopecia; Dapsone; Diagnosis, Differential; Facial Dermatoses; Humans; Male; M | 1989 |
Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.
Topics: Acute Disease; Animals; Chronic Disease; Cicatrix; Cytoplasmic Granules; Dapsone; Escherichia coli; | 1989 |
Plasmodium vivax resistance to chloroquine?
Topics: Acute Disease; Animals; Antimalarials; Blood Specimen Collection; Chloroquine; Dapsone; Drug Adminis | 1989 |
Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
Topics: Acute Disease; Adolescent; Antimalarials; Dapsone; Drug Combinations; Humans; Immunosuppression Ther | 1988 |
Leprosy.
Topics: Acute Disease; Dapsone; Diagnosis, Differential; Humans; Leprosy; Peripheral Nervous System Diseases | 1968 |
Letter: An acute attack of quartan malaria in a leprosy patient being treated with diaminodiphenylsulphone.
Topics: Acute Disease; Adult; Dapsone; Humans; Leprosy; Malaria; Malaysia; Male; Plasmodium malariae | 1974 |
Curative and suppressive treatment of P. falciparum malaria with oral and parenteral Fansidar.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Chloroquine; Dapson | 1971 |